Antimicrobial Peptides and Skin: A Paradigm of Translational Medicine

Episode von Medizin - Open Access LMU - Teil 19/22 von Ludwig-Maximilians-Universität München · 1. Januar 2012

Antimicrobial peptides (AMPs) are small, cationic, amphiphilic peptides with broad-spectrum microbicidal activity against both bacteria and fungi. In mammals, AMPs form the first line of host defense against infections and generally play an important role as effector agents of the innate immune system. The AMP era was born more than 6 decades ago when the first cationic cyclic peptide antibiotics, namely polymyxins and tyrothricin, found their way into clinical use. Due to the good clinical experience in the treatment of, for example, infections of mucus membranes as well as the subsequent understanding of mode of action, AMPs are now considered for treatment of inflammatory skin diseases and for improving healing of infected wounds. Based on the preclinical findings, including pathobiochemistry and molecular medicine, targeted therapy strategies are developed and first results indicate that AMPs influence processes of diseased skin. Importantly, in contrast to other antibiotics, AMPs do not seem to propagate the development of antibiotic-resistant micro-organisms. Therefore, AMPs should be tested in clinical trials for their efficacy and tolerability in inflammatory skin diseases and chronic wounds. Apart from possible fields of application, these peptides appear suited as an example of the paradigm of translational medicine for skin diseases which is today seen as a `two-way road' - from bench to bedside and backwards from bedside to bench. Copyright (c) 2012 S. Karger AG, Basel

Weitere Episoden von „Medizin - Open Access LMU - Teil 19/22“

• Appraisal of WHO guidelines in maternal health using the AGREE II assessment tool. 1. Januar 2012
• Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study. 1. Januar 2012
• Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen 1. Januar 2012
• Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% 1. Januar 2012
• Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. 1. Januar 2012
• Body fat free mass is associated with the serum metabolite profile in a population-based study. 1. Januar 2012
• Botulinum Toxin A for the Treatment of Keloids 1. Januar 2012
• Color in context: psychological context moderates the influence of red on approach- and avoidance-motivated behavior. 1. Januar 2012
• Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema 1. Januar 2012
• Cultured subventricular zone progenitor cells transduced with neurogenin-2 become mature glutamatergic neurons and integrate into the dentate gyrus. 1. Januar 2012
• DRGs in Transfusion Medicine and Hemotherapy in Germany 1. Januar 2012
• Efficacy and Patient-Reported Outcomes of a New Mometasone Cream Treating Atopic Eczema 1. Januar 2012
• Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale 1. Januar 2012
• Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. 1. Januar 2012
• Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue 1. Januar 2012

Alle Episoden von Medizin - Open Access LMU - Teil 19/22 · Mehr Bildung-Podcasts